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Lay summary 
Iron depletion by repeated venesection is the mainstay of treatment for 
Haemochromatosis, an iron overload disorder. Venesection has been associated 
with several health benefits including improvement in liver function tests, the 
reversal of liver scarring, and a reduced risk of liver cancer. During iron 
depletion, iron absorption from the gastro-intestinal (GI) tract increases to 
compensate for iron lost with treatment. Iron availability is limited in the GI tract 
and is critical to the growth and function of many gut bacteria. In this study we 
show that reduced iron availability in the colon following venesection treatment 
leads to a change in the composition of the gut bacteria, a finding which to date 




Background & Aims: Iron reduction by venesection has been the cornerstone of 
treatment of Hemochromatosis for decades; its reported health benefits are 
many. Repeated phlebotomy can lead to a compensatory increase in intestinal 
iron absorption, reducing intestinal iron availability. As most gut bacteria are 
highly dependent on iron for survival, we postulated that by reducing gut iron 
levels, venesection could alter the gut microbiota. Methods: Clinical parameters, 
faecal bacterial composition and metabolomes were assessed before and during 
treatment in a group of Haemochromatosis patients undergoing iron reduction 
therapy. Results: Here we show that systemic iron reduction is associated with 
an alteration of the gut microbiome, with changes evident in those who 
experienced reduced faecal iron availability with venesection. For example, 
levels of F. prausnitzii, a bacteria associated with improved colonic health, were 
increased by faecal iron reduction. Similarly, metabolomic changes were seen in 
association with reduced faecal iron levels. Conclusion: These findings highlight 
a significant shift in the gut microbiome of patients who experience reduced 
colonic iron during venesection. Targeted depletion of faecal iron may represent 




Venesection is the standard therapy for patients with Hereditary 
Haemochromatosis (HH), the commonest iron overload condition. Venesection 
typically involves the removal of 500mls of blood (equivalent to 250mg of iron) 
weekly from patients until normal iron levels are achieved. Repeated 
phlebotomy in HH has been associated with an enhanced quality of life and 
increased energy levels, an improvement in liver function tests and a reversal of 
liver fibrosis, as well as a reduction in cancer risk.(1-3) The factors mediating 
these benefits are largely unknown. 
 
Studies have indicated that patients undergoing venesection experience 
increased intestinal iron absorption during treatment,(4) leading to reduced 
faecal iron excretion.(5) As iron is a vital nutrient for the growth of many gut 
bacteria,(6) changes in intestinal iron availability during phlebotomy could have 
implications for the microbes residing in the colon. Conversely, oral iron 
supplementation has been shown to adversely affect the composition and 
function of the human gut microbiome,(7) while differences in gut bacteria have 
been demonstrated comparing iron deficient with iron replete individuals.(8) 
Moreover, increased colonic iron has been associated with colonic inflammation 
and oxidative stress and therefore, reducing colonic iron may confer a 
therapeutic benefit.(9-11) 
 
In this study, we aimed to determine the relationship between gut bacteria and 
faecal iron levels before and during phlebotomy. Stool samples were collected 
from patients initiating treatment (characteristics outlined in supplementary 
table 1), with paired samples obtained from 11 of these patients during follow 
up. Faecal iron levels were measured, and their relationship with the gut 
microbiome was assessed by 16S metagenomic sequencing and metabolomic 
analysis of faecal water. 
 
Methods 
Study Population and Design 
20 patients (10 C282Y homozygotes, 4 compound C282Y/H63D heterozygotes, 6 
with non-HFE hyperferritinaemia) initiating therapeutic venesection at the John 
Radcliffe Hospital, Oxford were enrolled alongside standard clinical care. Written 
informed consent was obtained from all study subjects. The study conformed to 
the ethical guidelines of the 1975 Declaration of Helsinki, and patients were 
recruited through the Oxford GI Biobank (Gastrointestinal Illness in Oxford: 
prospective cohort for outcomes, treatment, predictors and biobanking REC Ref: 
16/YH/0247). Patients were requested not to modify their diet during the study 
period. No patients reported antibiotic use within 6 weeks before, or during the 
study period. Stool samples from 5 healthy controls were obtained for 
comparison of baseline faecal iron levels. 
 
Treatment protocol 
Venesection was initiated according to unit protocol; individuals were deemed to 
have iron overload by their treating Hepatologist, with a serum ferritin level 
>300μg/L in men and >200μg/L in women in combination with an elevated 
fasting transferrin saturation (>45%) for men and women. All patients were 
treated by a nurse-led venesection service, aiming to achieve an initial serum 
ferritin target of 50-100μg/L through weekly or fortnightly venesection. Each 
venesection would typically involve in the removal of 500mls blood (250mg 
iron). Venesection intervals would be increased, or less volume of blood would 
be removed should the patient not tolerate phlebotomy (due to weakness, 
hypotension, or the development of anaemia, for instance). 
 
Metagenomic DNA extraction 
DNA was extracted from all samples using a commercially available kit (FastDNA 
spin kit for soil; MP Biomedicals, USA, Cat No. 6560200). Samples were thawed 
on ice, homogenized, and DNA was extracted from approximately 200mg of each, 
with an additional bead beating step using FastPrep.(12) 
 
16S rRNA gene amplification and sequencing 
The impact of iron on the composition of the human gut microbiome was 
investigated using high throughput 16S rRNA gene (V4 region) sequencing using 
the Illumina Miseq platform. Sequencing produced 980,0284 high-quality reads, 
with an average of 224,980 ± 50072 reads per sample. Data analysis was 
performed using the Quantitative Insights into Microbial Ecology (QIIME, V1.9) 
pipeline. ChimeraSlayer was used to filter trimmed reads for chimeric sequences.  
 
Comparison of taxa composition according to response to venesection by 
LEfSe 
Linear discriminant analysis effect size (LEfSe)(13), was employed to identify 
and characterise the differences in abundance of genera between faecal samples 
according to response to venesection.  Differentially abundant taxa were 
identified using non-parametric Kruskal-Wallis sun-rank test (p=0.05), followed 
by linear discriminant analysis (LDA) estimating effect size of each differentially 
abundant genus.  Differences in abundance were considered statistically 
significant if logarithmic LDA score was >2.0. 
 
Short chain fatty acid quantification in cultured microbiomes 
Briefly, 0.2g of faecal sample was mixed with 12x volume of NMR buffer, and 
1mM sodium 3-(Trimethylsilyl)-propionate-d4 (TSP) as a chemical shift 
reference. The 1H NMR spectra were recorded at 600 MHz on a Bruker Avance 
spectrometer (Bruker BioSpin GmbH, Germany) running Topspin 2.0 software. 
The metabolites were quantified using the software Chenomx® NMR Suite 7.0TM. 
 
Measuring Total Iron Concentrations in Stool Samples 
Free faecal iron refers to unbound iron, which is typically kept at very low levels 
to prevent the production of toxic reactive oxygen species, or its use by 
pathogens for growth. The vast majority of iron within the colonic lumen is 
derived from the diet, with approximately 90% of dietary iron in the non-haem 
iron form; iron may is bound to non-haem compounds (ferritin) or haem 
compounds (haemoproteins) or haem enzymes. Total faecal iron includes both 
bound and unbound iron. (14). 
 
Flame atomic absorption spectrophotometry (FAAS) was used to determine the 
concentration of iron in faecal samples. Faecal samples were thawed, weighed 
and then dried at 110oC in an oven. The sample was re-measured again to 
calculate water content, transferred into glass crucibles and ashed in a muffle 
furnace for 48 hrs at 600oC. The ashed sample was resuspended in 20% 16M 
HNO3 and crucibles were then placed on a hot plate until sample had almost 
evaporated. This was then diluted to a final volume of 25 mL of 1M HCL. The 
spectrophotometer (Perkin Elmer Atomic Absorption Spectrophotometer Model 
3300) was calibrated against a range of iron standards and samples were 
measured at an absorption wavelength of 248.3nm. 
 
Measuring Available Iron in Stool Samples 
0.2g faecal sample was homogenised with a known volume of Milli-Q water, 
mixed on a rotator stirrer for 30 min at the room temperature and centrifuged at 
3,000g for 15 min at 4oC. Supernatants were analysed using the Ferrozine assay, 
where iron in the sample is reduced using an Fe reducer provided by the kit after 
which iron reacts with Ferene S (an iron chromogen) to produce a stable 
coloured complex and give absorbance at 593 nm.  
 
Gene expression analysis 
Profiling of gut bacterial species was performed using the Metabolic Disorders 
qPCR array for microbial DNA testing of 45 specific bacterial species implicated 
in metabolic dysfunction such as obesity and type 2 diabetes mellitus (Qiagen) 
and Microbial DNA qPCR Assay for Hs.GAPDH. Data was analysed using the 2-
ΔΔCt method with GAPDH as internal control gene and using the mean of the 
control duplicates as control. 
 
Statistical Analyses 
Continuous, normally distributed variables are reported as mean +/-standard 
deviation (SD), or median (range) for non-Gaussian distribution. Categorical 
variables are presented as number (percent). Comparison between groups was 
performed using Student’s t-test or Mann Whitney U tests and analysis of 
variance (ANOVA) or Kruskal-Wallis test as appropriate, for continuous 
variables. Correlations were performed by Pearson’s correlation or Spearman 
Rank method. Data analysis used Graphpad Prism 6.0®. A p-value of <0.05 was 
considered statistically significant. 
 
Results and Discussion 
Free iron levels in stool samples were significantly higher in venesection 
patients at baseline when compared with that of healthy controls (figure 1). As 
expected, treatment with venesection was associated with a significant reduction 
in serum ferritin levels, and an improvement in liver enzymes (figure 1). Of the 
11 patients with paired samples from baseline and during treatment, no 
significant change in total faecal iron levels was noted with treatment (data not 
shown). However, free faecal iron levels decreased significantly on follow up in 6 
patients (group A, reduced faecal iron), while no change was observed in 
samples from 5 patients (group B, unchanged faecal iron; characteristics 
outlined in supplementary table 2). No significant differences in age or gender, 
baseline or treatment serum ferritin, or baseline faecal free iron levels were 
noted between groups, although comparisons were limited by small sample size. 
However, individuals in the group A had significantly more iron removed by 
phlebotomy [2.7g (+/-0.8) vs. 1.1g (+/-0.7)] and were all homozygous for C282Y 
mutation in the HFE gene; only these patients experienced significant 
biochemical improvements when compared with group B, including reductions 
in ALT [43 (+/-11) IU/ml to 28 (+/-4) IU/ml, vs. 39 (+/-28) IU/ml to 22 (+/-9) 
IU/ml; supplementary figure 1a] and HbA1c levels [33 (+/-4) mmol/mol to 27 
(+/-4) mmol/mol, vs. 33 (+/-4) mmol/mol to 34 (+/-1) mmol/mol]. Free faecal 
iron correlated with ALT levels in group A (rho=0.76, p=0.0052; supplementary 
figure 1b), while no significant relationship was evident in group B. No 
significant relationship between markers of colonic inflammation such as CRP or 
WCC was evident (these parameters were largely normal in the study cohort; 




Fig. 1. Baseline and on treatment iron and biochemical changes. 1a Patients with 
iron overload had significantly higher faecal free iron levels than healthy controls. 
Significant reductions in serum ferritin and ALT were seen in paired samples on 
treatment (1b and 1c; note: one ALT datapoint missing in treatment group). Free faecal 
iron fell significantly with treatment (1d). Of these, 6 individuals had a significant 
reduction in faecal free iron (group A; reduced faecal iron), while 5 did not (group B; 
unchanged faecal iron, 1e). Group A had significantly more iron removed by venesection 
than group B (1f). Graphs are presented as mean +/-SEM. *p<0.05 **p<0.005. 
 
 
The effect of treatment on the gut microbiota was compared between groups in 
order to assess the impact of changes in faecal free iron. While no difference in 
phylogenetic beta diversity was evident between baseline and treatment in both 
groups, significant changes in microbiome community composition were found 
at 16S sequencing using LEfSe analysis (figure 2). Furthermore, levels of 3 
bacterial species (of 45 assayed by qPCR), namely Faecalibacterium prausnitzii, 
Dorea formicigenerans and Collinsella aerofaciens were increased with those with 




Fig. 2. Changes in bacterial composition with iron reduction. Linear discriminant 
analysis effect size (LEfSe) analysis of faecal samples stratified by response to 
venesection.  Linear discriminant analysis effect size (LEfSe) identified taxa with 
differential relative abundance between categories (p<0.05).  Data indicate linear 
discriminant analysis (LDA) showing effect size greater than log LDA=2 which were 
deemed statistically significant. Baseline faecal samples of patients stratified according 
to eventual response to venesection (2a); Differentially abundant taxa in faecal samples 
after venesection (2b). Significant changes in 3 bacterial Species were evident in those 
with reduced faecal free iron following venesection (group A, *p<0.05; Fig 2c-e). Graphs 
are presented as mean +/-SEM. 
 
Similarly, significant changes in microbial metabolites after treatment were only 
evident in group A, where an increase in pyruvate, tyrosine, methionine, glycine, 
and aspartate was observed (supplementary figure 1). In these patients, a 
greater separation in the metabolome was illustrated, where a shift was 
observed towards a more positive metabolomic profile with treatment compared 
to baseline. In contrast, a less distinct shift in the metabolomic profile was 
evident in group B (supplementary figure 1). 
 
LEfSe analysis of faecal samples before and after venesection demonstrated 
changes in the faecal microbiome in patients in response to altered iron 
availability. A significant increased abundance of the pathobiont Escherichia in 
faecal samples of patients who did not response to iron reduction through 
venesection was noted (Figure 2b).  Interestingly, this mirrors findings from a 
study reporting differential reduction in Escherichia relative abundance in 
response to iron chelation(9). In addition, LEfSe analysis identified increased log 
LDA abundance of Desulfovibrio, (Figure 2b) a sulphate-reducing member of 
Proteobacteria phylum associated with iron metabolism through reduction of 
iron oxides(15).  These data, and the changes seen in participant faecal 
microbiome analysis support previously published data which propose that 
haem iron, through its impact on mucosal homeostasis, can alter the colonic 




Strikingly, in a study by Lee et al. examining the effect of oral and intravenous 
iron supplementation on patients with inflammatory bowel disease,(8) oral iron 
supplementation was associated with decreased abundances of the bacterial 
species Faecalibacterium prausnitzii, Dorea formicigenerans and Collinsella 
aerofaciens; in this study the reduction in colonic iron was associated with an 
increase in these exact species, aligning findings with 2 independent approaches. 
In particular, a depletion of Faecalibacterium prausnitzii has been implicated in 
several diseases including fatty liver disease and inflammatory bowel disease, 
and therapies to augment its abundance would be of potential clinical benefit. An 
increase in the relative abundance of Collinsella was also found, and both of these 
bacterial genera are associated with production of potentially beneficial short 
chain fatty acids such as acetate and butyrate, although no change in these 
metabolites was noted in this study.(17, 18)  
 
This is the first description of the gut microbiome in patients with 
Haemochromatosis, a condition in which excess systemic iron can lead to multi-
organ damage, including liver fibrosis and primary liver cancer. Iron reduction 
by venesection can significantly reduce the risk of these complications. Despite 
being limited by small numbers, this study reveals a clear effect of colonic iron 
depletion on the gut microbiome during venesection. Individuals who 
experienced a beneficial effect of venesection on their microbiome profiles had 
undergone a greater amount of iron removal than those who did not. This likely 
reflects a greater initial iron burden, and a better tolerance to venesection, 
conferred by their HFE genotype. This pilot study does not, however, include 
mechanistic data to determine whether or not the changes noted in microbial 
composition could account for improvements in disease. 
 
Conclusion 
Overall, a general shift towards a healthier systemic and metabolic profile was 
observed in HH patients who responded positively to iron reduction via 
venesection. This was accompanied with an increase in beneficial bacterial 
species in the large intestine, as well improved as metabolomic profiles. 
Regulating the availability of colonic iron may represent a novel therapy for 
metabolic and inflammatory disorders through the manipulation of the gut 
microbiome, and merits further investigation. 
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• Venesection is the cornerstone of Haemochromatosis treatment  
• Venesection leads to a compensatory increase in intestinal iron 
absorption 
• Reduced faecal iron availability leads to shifts in human colonic microbial 
composition 
• Changes in the human colonic metabolome occur with reduced faecal iron 
availability 
 
